A new report released Tuesday by Sen. Bernie Sanders (I-Vt.) takes aim at the prices and executive compensation of three major drug manufacturers, previewing his lines of attack for when the companies’ CEOs appear at a hearing later this week. In the report prepared by Democratic staff on the Senate Health, Education, Labor and Pensions Committee, longtime industry critic Sanders accused Johnson & Johnson (J&J), Merck and Bristol Myers Squibb of “ripping off the American people.” For some of their most popular drugs, the report noted the companies made more money in the U.S. than the rest of the world combined. The companies start by setting high prices for new drugs and then raise pr
Hence then, the article about sanders slams drugmakers business practices in new report ahead of ceo hearing was published today ( ) and is available onTOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Sanders slams drugmakers’ business practices in new report ahead of CEO hearing )